Mass Spectrometry Services Now Available
We are thrilled to announce the launch of our Early Access to Mass Spectrometry services in Singapore, featuring our cutting-edge Rapid Data-Independent Acquisition (DIA) Proteomics services on Orbitrap Astral and Untargeted Metabolomics on Q Exactive HF-X platform.
Explore Multiomics with Mass Spectrometry & mRNA-sequencing or Metagenomics
Unlock the full potential of your research with the powerful synergy of Mass Spectrometry and mRNA-sequencing. Together, they decode the complex interplay between transcriptomics and metabolism, driving breakthroughs in disease research, phenotypic diversity, and therapeutic innovation.

Explore microbial ecosystems and biochemical dynamics with the power of Mass Spectrometry and Shotgun Metagenomics. We aim to empower researchers to identify actionable biomarkers, illuminate disease pathways, and accelerate the path to targeted solutions with the latest technologies.

Ready to elevate your discoveries? Let’s make it happen together.
Go Deeper

Quantify up to 8000 proteins* per sample with Orbitrap Astral's high protein coverage and sensitivity via label-free quantitation through Rapid Data-Independent Acquisition (DIA) Proteomics

*Single injection of 200 ng HeLa cell lines with a run-to-run time of 8 minutes
Explore Multiomics

Take your research to the next level with multiomics. For a limited-time only, we're offering complimentary mRNA-sequencing or Shotgun metagenomics services when you purchase any of our Mass Spectrometry products
Lightning-fast Results

Our lab is equipped with multiple mass spectrometry systems, so rest assured that your samples are processed promptly without delays

Experience the power of multiomics when you purchase any of our Mass Spectrometry services. Receive complimentary mRNA-seq or Shotgun Metagenomics for an equivalent number of samples* for a limited-time only
Rapid DIA Service Overview Untargeted Metabolomics
Proteins (peptides) Analytes Metabolites
Peptide samples Accepted sample types Prepared Metabolites samples
12 samples Minimum quantity 12 samples
4-6 weeks Turnaround time (TAT) 4-6 weeks
Orbitrap Astral Platform used Q Exactive HF-X
raw Standard data delivery mzXML
Terms and Conditions*
• This promotion is valid from 1st December 2024 to 31st March 2025.
• This promotion is available exclusively for Singapore customer, with a minimum requirement of 12 samples, in a single batch.
• Peptide samples can be submitted starting December 2024.
• To qualify for the promotion, both the purchase order (PO) and samples must be received by 31st March 2025. 
• Raw materials are accepted starting April 2025 but are excluded from this current promotion.
• The complimentary RNA-seq and metagenomics services cover library preparation and sequencing costs only. Costs for extraction and bioinformatic analysis are not included. Bioinformatic analysis can be separately arranged through your sales representative.
• The details of this promotion may be subjected to changes. NovogeneAIT Genomics reserves the right to interpret and modify these terms as necessary.
References
1. Wang H, Liu C, Xie X, et al. Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. Immunity. 2023;56(6):1410-1428.e8.
2. Kang L, Qian L, Zheng M, et al. Genomic insights into the origin, domestication and diversification of Brassica juncea. Nat Genet. 2021 Sep;53(9):1392-1402.
3. Song Y, Chen P, Xuan A, et al. Integration of genome wide association studies and co-expression networks reveal roles of PtoWRKY 42-PtoUGT76C1-1 in trans-zeatin metabolism and cytokinin sensitivity in poplar. New Phytol. 2021 Aug;231(4):1462-1477.
4. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017 Feb 1;5(1):14
5. Davar D, Dzutsev AK, McCulloch JA, et al. Fecal microbiota transplant overcomes resistance to anti-PD- 1 therapy in melanoma patients. Science, 2021,371(6529):595-602.
 
About NovogeneAT Genomics
NovogeneAIT Genomics is a leading multi-omics services and solutions provider headquartered in Singapore. It is formed as a strategic joint venture between Novogene and AITbiotech, a Singapore biotech Company in 2016. With an unwavering commitment to delivering high-quality, swift, and cost-effective omics solutions, NovogeneAIT Genomics has grown to become one of the largest NGS service providers in Southeast Asia. It offers a comprehensive suite of multi-omics services encompasses genomics, transcriptomics, single cell/spatial transcriptomics, metagenomics, and proteomics. Operating from our state-of-the-art sequencing center in Singapore, NovogeneAIT is dedicated to advancing genomic research by offering unmatched data quality that empowers researchers across diverse sectors, including healthcare and agriculture, to realize their research goals.

For more information, visit novogene.com/amea-en/.
 
© 2024 Novogene Co., Ltd. All Rights Reserved
      
 
NovogeneAIT Genomics Pte. Ltd.
(Regional Office for Asia Pacific, Middle-East & Africa)
11 Biopolis Way, #10-11 Helios,
Singapore 138667  
 
Novogene Japan K.K.
Kayabacho-Nagaoka BLDG3-7F, 2-7-10,
Nihonbashi-Kayabacho, Chuo City,
Tokyo,103-0025 Japan
 
Novogene (HK) Company Limited
Unit 1307, Everglory Centre,
1B Kimberly Street, 
Tsim Sha Tsui, Hong Kong